Market
Wall Street Analyst Initiated CASI Pharmaceuticals Inc [CASI]. What else is Wall St. saying
CASI Pharmaceuticals Inc [NASDAQ: CASI] closed the trading session at $5.66. The company report on March 5, 2024 at 7:00 AM that CASI Pharmaceuticals Report Positive Interim Phase 1 Data For BI-1206 In The Treatment Of Relapsed/Refractory Indolent Non-Hodgkin’s Lymphoma In China. CASI Pharmaceuticals, Inc.
